Ameren Co. (NYSE:AEE - Free Report) - Investment analysts at Zacks Research lifted their Q2 2025 earnings per share estimates for Ameren in a research report issued on Thursday, May 22nd. Zacks Research analyst R. Department now expects that the utilities provider will post earnings per share of $1.02 for the quarter, up from their prior estimate of $0.84. The consensus estimate for Ameren's current full-year earnings is $4.93 per share. Zacks Research also issued estimates for Ameren's Q3 2025 earnings at $1.77 EPS, Q4 2025 earnings at $1.01 EPS, Q2 2026 earnings at $1.14 EPS, Q3 2026 earnings at $1.65 EPS, Q4 2026 earnings at $1.37 EPS and FY2026 earnings at $5.30 EPS.
Ameren (NYSE:AEE - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The utilities provider reported $1.07 earnings per share for the quarter, missing the consensus estimate of $1.08 by ($0.01). The business had revenue of $2.10 billion for the quarter, compared to analyst estimates of $1.92 billion. Ameren had a return on equity of 10.34% and a net margin of 15.51%. Ameren's revenue for the quarter was up 15.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.98 EPS.
Several other brokerages have also commented on AEE. Barclays increased their price objective on Ameren from $101.00 to $104.00 and gave the company an "equal weight" rating in a research report on Tuesday, May 6th. Wells Fargo & Company lifted their price target on Ameren from $108.00 to $112.00 and gave the company an "overweight" rating in a research report on Wednesday, May 14th. Guggenheim restated a "neutral" rating on shares of Ameren in a report on Tuesday, April 22nd. BMO Capital Markets boosted their target price on Ameren from $106.00 to $108.00 and gave the stock an "outperform" rating in a research report on Monday, May 5th. Finally, KeyCorp raised Ameren from a "sector weight" rating to an "overweight" rating and set a $103.00 price target on the stock in a report on Wednesday, May 14th. Four equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Ameren currently has an average rating of "Moderate Buy" and a consensus target price of $101.90.
Get Our Latest Research Report on Ameren
Ameren Stock Performance
AEE stock traded up $0.50 during midday trading on Monday, hitting $96.67. The company's stock had a trading volume of 88,582 shares, compared to its average volume of 1,557,139. The company has a quick ratio of 0.44, a current ratio of 0.66 and a debt-to-equity ratio of 1.41. The stock has a market cap of $26.13 billion, a price-to-earnings ratio of 21.85, a PEG ratio of 2.97 and a beta of 0.51. Ameren has a 1 year low of $69.39 and a 1 year high of $104.10. The stock's 50-day moving average price is $97.72 and its 200 day moving average price is $95.36.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in the company. Wells Fargo & Company MN raised its holdings in Ameren by 1,732.4% during the fourth quarter. Wells Fargo & Company MN now owns 3,068,505 shares of the utilities provider's stock worth $273,527,000 after purchasing an additional 2,901,047 shares during the last quarter. FMR LLC raised its stake in shares of Ameren by 96.5% during the 4th quarter. FMR LLC now owns 5,170,709 shares of the utilities provider's stock worth $460,917,000 after buying an additional 2,539,129 shares during the last quarter. T. Rowe Price Investment Management Inc. boosted its position in shares of Ameren by 16.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 17,038,754 shares of the utilities provider's stock worth $1,518,835,000 after buying an additional 2,439,811 shares in the last quarter. Nuveen LLC acquired a new stake in Ameren in the 1st quarter valued at about $241,496,000. Finally, Price T Rowe Associates Inc. MD grew its stake in Ameren by 5.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 28,404,577 shares of the utilities provider's stock valued at $2,851,821,000 after acquiring an additional 1,355,848 shares during the last quarter. 79.09% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Ameren
In related news, insider Shawn E. Schukar sold 4,743 shares of the business's stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $103.79, for a total transaction of $492,275.97. Following the completion of the sale, the insider now owns 57,486 shares in the company, valued at $5,966,471.94. The trade was a 7.62% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Chonda J. Nwamu sold 5,500 shares of the firm's stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $101.37, for a total value of $557,535.00. Following the transaction, the executive vice president now owns 43,344 shares in the company, valued at $4,393,781.28. This represents a 11.26% decrease in their position. The disclosure for this sale can be found here. 0.42% of the stock is owned by corporate insiders.
Ameren Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Tuesday, June 10th will be paid a dividend of $0.71 per share. The ex-dividend date is Tuesday, June 10th. This represents a $2.84 dividend on an annualized basis and a dividend yield of 2.94%. Ameren's payout ratio is 62.97%.
Ameren Company Profile
(
Get Free Report)
Ameren Corporation, together with its subsidiaries, operates as a public utility holding company in the United States. The company operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. It engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution business.
See Also
Before you consider Ameren, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ameren wasn't on the list.
While Ameren currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
